On December 24, 2021, Abpro Bio Co., Ltd. closed the transaction. The company amended the terms of the transaction and issued 7,159,904 shares at a price of KRW 838 for gross proceeds of KRW 5,999,999,552. The transaction involved participation from returning investor Veritas Fund.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
525 KRW | -0.19% | +2.74% | -3.67% |
1st Jan change | Capi. | |
---|---|---|
-3.67% | 110M | |
+74.12% | 4.37B | |
+6.05% | 2.1B | |
+8.87% | 2.1B | |
-11.50% | 1.49B | |
-0.63% | 1.49B | |
+16.61% | 1.41B | |
-29.42% | 1.34B | |
-16.74% | 1.28B | |
-1.56% | 1.21B |
- Stock Market
- Equities
- A195990 Stock
- News Abpro Bio Co., Ltd.
- Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding